A brain-targeting lipidated peptide for neutralizing RNA-mediated toxicity in Polyglutamine Diseases. [PDF]
Zhang Q +12 more
europepmc +1 more source
Post-translational Modifications and Protein Quality Control in Motor Neuron and Polyglutamine Diseases. [PDF]
Sambataro F, Pennuto M.
europepmc +1 more source
Nanoscale studies link amyloid maturity with polyglutamine diseases onset. [PDF]
Ruggeri FS +6 more
europepmc +1 more source
Uncoupling the Trade-Off between Somatic Proteostasis and Reproduction in Caenorhabditis elegans Models of Polyglutamine Diseases. [PDF]
Shemesh N +4 more
europepmc +1 more source
Aggregation formation in the polyglutamine diseases: protection at a cost? [PDF]
Todd TW, Lim J.
europepmc +1 more source
DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases. [PDF]
Bettencourt C +24 more
europepmc +1 more source
Oligonucleotide-based strategies to combat polyglutamine diseases. [PDF]
Fiszer A, Krzyzosiak WJ.
europepmc +1 more source
RNA-mediated pathogenic mechanisms in polyglutamine diseases and amyotrophic lateral sclerosis. [PDF]
Chan HY.
europepmc +1 more source
Are long-range structural correlations behind the aggregration phenomena of polyglutamine diseases? [PDF]
Moradi M, Babin V, Roland C, Sagui C.
europepmc +1 more source
CAG expansion induces nucleolar stress in polyglutamine diseases. [PDF]
Tsoi H +4 more
europepmc +1 more source

